Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Agent Efficacy
100%
Angiogenesis
11%
Apoptosis Induction
11%
Cardiac Magnetic Resonance Imaging (cMRI)
11%
Caspase-3 Activation
11%
Chemotherapy
11%
Clinical Model
11%
Clinical Practice
11%
Diallyl Trisulfide
100%
Dose-dependent
11%
Enzyme Assay
11%
Ex Vivo Slice Culture
11%
Glioblastoma
100%
Gross Tumor Volume
11%
H&E Staining
11%
H3-H4
11%
Hematoxylin
11%
Hepatic Function
11%
High Dose
11%
Histological Assessment
11%
Histone Acetylation
11%
Histone Deacetylase Inhibitor (HDACi)
100%
Histone H3
11%
Human Glioblastoma
33%
Induced Cell Death
11%
Intraperitoneal Injection
11%
Orthotopic Xenograft
11%
Orthotopic Xenograft Model
33%
Patient-derived Xenograft
44%
Radiotherapy
11%
Response to Therapy
11%
Slice Culture
11%
Surgical Intervention
11%
Therapeutic Agents
11%
Treatment Efficacy
11%
Tumor Progression
11%
Tumor Response
11%
Tumor Size
11%
U87MG
22%
Well Tolerated
11%
Western Blotting
11%
Xenograft Model
11%
Medicine and Dentistry
Angiogenesis
11%
Caspase 3
11%
Cell Death
11%
Cell Line
11%
Chemotherapy
11%
Diallyl Trisulfide
100%
Drug Megadose
11%
Enzyme Assay
11%
Ex Vivo
22%
Glioblastoma
100%
Haematoxylin
11%
Histone Acetylation
11%
Histone Deacetylase Inhibitor
100%
Histone H3
11%
Immunotherapy
11%
Intraperitoneal Drug Administration
11%
Liver Function
11%
Magnetic Resonance Imaging
11%
Neoplasm
33%
Programmed Cell Death
11%
Radiation Therapy
11%
Therapeutic Agent
11%
Tumor Progression
11%
Western Blot
11%
Xenograft
77%